Endocare Cryocare
This article was originally published in The Gray Sheet
Executive Summary
Cardiac surgical system cleared via 510(k) Aug. 3 uses cryoablation technology to treat arrhythmias including atrial fibrillation. The device uses specially designed malleable cryoprobes to create long linear lesions through the heart wall to block abberant electrical signals, the firm explains
You may also be interested in...
CryoCath/Endocare Deal Aimed At Minimally Invasive Cardiac Surgery Market
CryoCath anticipates that its five-year exclusive global supply and market access agreement with Endocare will allow for the development of a cryoablation device that can be used in keyhole surgery.
Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time
Small sterilizers told Medtech Insight that they were ready for the EPA’s controversial EtO emissions rule, while community advocates expressed concerns.